A Single-Arm, Prospective Study of Papaverine for the Treatment of Refractory Peripheral Neuropathy Induced by Taxane-Based Chemotherapy

Clinical trial NCT07572461 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07572461
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Chemotherapy-Induced Peripheral Neuropathy Refractory Chemotherapy-Induced Peripheral Neuropathy Paclitaxel-Induced Peripheral Neuropathy

Start date: 2026-05-01
Primary completion: 2027-05-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.